Repligen (RGEN)
(Delayed Data from NSDQ)
$142.85 USD
+2.42 (1.72%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $142.92 +0.07 (0.05%) 5:42 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Repligen (RGEN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$191.00 | $220.00 | $160.00 | 36.01% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for Repligen comes to $191.00. The forecasts range from a low of $160.00 to a high of $220.00. The average price target represents an increase of 36.01% from the last closing price of $140.43.
Analyst Price Targets (12)
Broker Rating
Repligen currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on 14 recommendations.
Of the 14 recommendations deriving the current ABR, 10 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 71.43% and 7.14% of all recommendations. A month ago, Strong Buy made up 71.43%, while Buy represented 7.14%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 10 | 9 | 9 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.50 | 1.50 | 1.50 | 1.54 | 1.54 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/27/2024 | Wells Fargo Securities | Brandon Couillard | Not Available | Strong Buy |
8/19/2024 | Not Identified | Not Identified | Hold | Hold |
8/5/2024 | The Benchmark Company | Robert Wasserman | Hold | Hold |
7/31/2024 | UBS | Dan Leonard | Strong Buy | Strong Buy |
7/30/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/30/2024 | SVB Securities | Puneet Souda | Strong Buy | Strong Buy |
6/18/2024 | Guggenheim Securities | Subbu Nambi | Not Available | Hold |
6/17/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
5/2/2024 | William Blair | Matt Larew | Strong Buy | Strong Buy |
5/1/2024 | Stephens | Jacob Johnson | Strong Buy | Strong Buy |
4/19/2024 | Craig-Hallum | Matthew G Hewitt | Strong Buy | Strong Buy |
2/15/2024 | KeyBanc Capital Markets | Paul Knight | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.50 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 14 |
Average Target Price | $191.00 |
LT Growth Rate | 23.40% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | 0.34 |
RGEN FAQs
Repligen Corporation (RGEN) currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms.
The average price target for Repligen Corporation (RGEN) is $191.00. The current on short-term price targets is based on 7 reports.
The forecasts for Repligen Corporation (RGEN) range from a low of $160 to a high of $220. The average price target represents a increase of $36.01 from the last closing price of $140.43.
The current UPSIDE for Repligen Corporation (RGEN) is 36.01%
Based on short-term price targets offered by 12 analysts, the average price target for Repligen comes to $191.00. The forecasts range from a low of $160.00 to a high of $220.00. The average price target represents an increase of 36.01% from the last closing price of $140.43.